Polaryx Therapeutics, Inc.(PLYX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLYX Polaryx Therapeutics, Inc.

盘前交易 03-02 06:13:29 EST

3.05

-0.14

-4.39%

盘前2.88

-0.17-5.57%

05:21 EST

最高3.41	最低3.01	成交量27.93万
今开3.25	昨收3.19	日振幅12.54%
总市值1.44亿	流通市值1.44亿	总股本4,734万
成交额89.41万	换手率0.59%	流通股本4,734万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLYX","market":"US","secType":"STK","nameCN":"Polaryx Therapeutics, Inc.","latestPrice":3.05,"timestamp":1772226000000,"preClose":3.19,"halted":0,"volume":279292,"hourTrading":{"tag":"盘前","latestPrice":2.88,"preClose":3.05,"latestTime":"05:21 EST","volume":404,"amount":1182.5601159999999,"timestamp":1772446897278,"change":-0.17,"changeRate":-0.055738,"amplitude":0.052459},"delay":0,"changeRate":-0.04388714733542324,"floatShares":47343297,"shares":47343297,"eps":-0.173,"marketStatus":"盘前交易","change":-0.14,"latestTime":"03-02 06:13:29 EST","open":3.25,"high":3.41,"low":3.01,"amount":894133.9551352,"amplitude":0.125392,"askPrice":3,"askSize":114,"bidPrice":2.81,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.173,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772461800000},"marketStatusCode":1,"adr":0,"listingDate":1769749200000,"exchange":"NASDAQ","adjPreClose":3.05,"preHourTrading":{"tag":"盘前","latestPrice":2.88,"preClose":3.05,"latestTime":"05:21 EST","volume":404,"amount":1182.5601159999999,"timestamp":1772446897278,"change":-0.17,"changeRate":-0.055738,"amplitude":0.052459},"postHourTrading":{"tag":"盘后","latestPrice":3.04,"preClose":3.05,"latestTime":"19:59 EST","volume":8324,"amount":25333.7914,"timestamp":1772240394697,"change":-0.01,"changeRate":-0.003279,"amplitude":0.036066},"volumeRatio":0.5733111760771737},"requestUrl":"/m/hq/s/PLYX","defaultTab":"news","newsList":[{"id":"1156072440","title":"Polaryx Therapeutics Inc：持续积极携手合同研究机构推进2026年上半年启动临床试验计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1156072440","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156072440?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:34","pubTimestamp":1771335254,"startTime":"0","endTime":"0","summary":"Polaryx Therapeutics Inc（简称PLYX）近日透露，公司正与其合同研究机构（CRO）保持紧密合作，全力推进相关临床试验的筹备工作。根据最新规划，该项试验预计将于2026年上半年正式启动。\n目前，双方团队正就试验方案设计、监管审批流程及执行细节等关键环节进行深入协调。这一进展标志着Polaryx Therapeutics Inc在创新药物研发领域迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLYX","BK4007"],"gpt_icon":0},{"id":"1138471055","title":"Polaryx Therapeutics 宣布直接登陆纳斯达克，股票代码“PLYX”即将开始交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1138471055","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138471055?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:33","pubTimestamp":1770039190,"startTime":"0","endTime":"0","summary":"Polaryx Therapeutics 已正式宣布，公司将通过直接上市方式登陆纳斯达克交易所。其普通股预计将于近期开始公开交易，股票交易代码定为“PLYX”。此次直接挂牌意味着该公司不发行新股，而是由现有股东直接将其持有的股份在公开市场进行交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLYX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polaryx.com","stockEarnings":[{"period":"1week","weight":0.1686},{"period":"1month","weight":-0.9322},{"period":"ytd","weight":-0.9322}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Polaryx Therapeutics, Inc.最初于2014年8月22日在怀俄明州注册成立。2025年10月24日，公司完成了重新注册过程，转为内华达州公司。Polaryx是一家临床阶段的生物技术公司，致力于发现、开发和商业化针对罕见儿童溶酶体储积病（LSDs）的创新疗法。公司采用多模式治疗方法，结合小分子药物疗法和基因疗法，旨在解决这些疾病的遗传原因和下游影响。其领先的药物候选产品PLX-200，针对多种LSDs，并已进入临床试验阶段。Polaryx的药物开发战略以提供安全、有效、以患者为中心的治疗方案为核心，旨在满足这些疾病尚未解决的重大需求。","exchange":"NASDAQ","name":"Polaryx Therapeutics, Inc.","nameEN":"Polaryx Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polaryx Therapeutics, Inc.(PLYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Polaryx Therapeutics, Inc.(PLYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Polaryx Therapeutics, Inc.,PLYX,Polaryx Therapeutics, Inc.股票,Polaryx Therapeutics, Inc.股票老虎,Polaryx Therapeutics, Inc.股票老虎国际,Polaryx Therapeutics, Inc.行情,Polaryx Therapeutics, Inc.股票行情,Polaryx Therapeutics, Inc.股价,Polaryx Therapeutics, Inc.股市,Polaryx Therapeutics, Inc.股票价格,Polaryx Therapeutics, Inc.股票交易,Polaryx Therapeutics, Inc.股票购买,Polaryx Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polaryx Therapeutics, Inc.(PLYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Polaryx Therapeutics, Inc.(PLYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}